Compugen (CGEN) Non-Current Deferred Tax Liability (2010 - 2015)
Compugen (CGEN) posted quarterly Non-Current Deferred Tax Liability of $105000.0 for Q3 2015, down 80.04% year-over-year from $526000.0 in Q3 2014, and down 50.0% on a QoQ basis from $210000.0 in Q2 2015.
Analysis
Compugen (CGEN) Non-Current Deferred Tax Liability (2010 - 2015) Analysis & Trends
Compugen has reported Non-Current Deferred Tax Liability for 6 years, with the latest figure at $105000.0 in Q3 2015.
- Non-Current Deferred Tax Liability for Q3 2015 came in at $105000.0, down 80.04% year-over-year; the trailing twelve-month figure through Sep 2015 was $105000.0 (down 80.04% YoY), and the FY2014 annual result was $421000.0, down 96.81% from the prior year.
- Non-Current Deferred Tax Liability eased to $105000.0 in Q3 2015, from $210000.0 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $14.2 million in Q1 2014 and troughed at $105000.0 in Q3 2015.
- A 5-year average of $5.8 million and a median of $4.8 million in 2012 frame the typical range for Non-Current Deferred Tax Liability.
- The widest annual swing landed in 2013, when Non-Current Deferred Tax Liability soared 142.68%; it then plunged 98.39% in 2015.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $6.1 million in 2011, then grew by 28.0% to $7.9 million in 2012, then soared by 67.54% to $13.2 million in 2013, then sank by 96.81% to $421000.0 in 2014, then plunged by 75.06% to $105000.0 in 2015.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $105000.0 in Q3 2015, $210000.0 in Q2 2015, and $316000.0 in Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Compugen | 241.50 Mn | 155.89 Mn | -92,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 105,000.00 |
| Jun 30, 2015 | 210,000.00 |
| Mar 31, 2015 | 316,000.00 |
| Dec 31, 2014 | 421,000.00 |
| Sep 30, 2014 | 526,000.00 |
| Jun 30, 2014 | 13.07 Mn |
| Mar 31, 2014 | 14.15 Mn |
| Dec 31, 2013 | 13.19 Mn |
| Sep 30, 2013 | 14.10 Mn |
| Dec 31, 2012 | 7.87 Mn |
| Sep 30, 2012 | 5.81 Mn |
| Jun 30, 2012 | 4.79 Mn |
| Mar 31, 2012 | 7.38 Mn |
| Dec 31, 2011 | 6.43 Mn |
| Sep 30, 2011 | 3.24 Mn |
| Jun 30, 2011 | 3.30 Mn |
| Mar 31, 2011 | 4.21 Mn |
| Dec 31, 2010 | 4.04 Mn |